Geron
$1.869876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$1.86
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.03 (+1.64%) As of 3:03 PM EDT today
Why Robinhood?
You can buy or sell Geron and other stocks, options, and ETFs commission-free!
About GERN
Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. Read More The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park, CA. The listed name for GERN is Geron Corporation Common Stock.
Employees
46
Headquarters
Foster City, California
Founded
1990
Market Cap
579.02M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
3.46M
High Today
$1.89
Low Today
$1.82
Open Price
$1.85
Volume
784.47K
52 Week High
$2.40
52 Week Low
$0.75
Collections
Analyst Ratings
100%
of 6 ratings
Buy
100%
Hold
0%
Sell
0%
GERN Earnings
-$0.20
-$0.13
-$0.07
$0.00
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
— per share
Actual
Expected Nov 5, After Hours